Cryogenics

Global Cryogenic Equipment Market, 2019-2027: Technological Advancement & Improved Innovations in Areas Like Immunotherapy & Regenerative Medicines are Likely to Enhance the Market Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 5, 2020
Other Science, Science, Life sciences, Articles, Biotechnology, Biopharmaceutical, Pharmaceutical industry, Pharmacy, Cryogenics, Pharmaceutical industry in India

Furthermore, growing needs for genetically live tissue drug therapy, biopharma therapy, and respiratory healthcare are urging the growth of the cryogenic equipment market.

Key Points: 
  • Furthermore, growing needs for genetically live tissue drug therapy, biopharma therapy, and respiratory healthcare are urging the growth of the cryogenic equipment market.
  • Additionally, technological advancement and improved innovations in areas like immunotherapy, vaccinations, biopharmaceuticals, and regenerative medicines are likely to enhance the market growth.
  • Globally, the cryogenic equipment market is rising at a CAGR of 7.4% for the estimated period from 2019 to 2027.
  • The Asia Pacific emerged as a dominant market for cryogenic equipment and accounted to hold a market share of around 38% in 2018.

Axonics® Announces Fourth Quarter and Fiscal 2019 Financial Results

Retrieved on: 
Wednesday, March 4, 2020
Biotechnology, Health, Surgery, Medical devices, Films, Cryogenics, Magnetic resonance imaging, Implant, Scanners, Creative works

In the fourth quarter of 2019, net revenue of the Axonics r-SNM System totaled $9.9 million.

Key Points: 
  • In the fourth quarter of 2019, net revenue of the Axonics r-SNM System totaled $9.9 million.
  • A total of 35 hospitals in England, the Netherlands, Switzerland, Germany and Canada implanted the Axonics r-SNM System in 2019.
  • In November 2019, Axonics raised approximately $118 million of gross proceeds in an underwritten public follow-on offering.
  • In December 2019, Axonics gained Health Canada approval for the use of 1.5T and 3T full body MRI scanners for patients implanted with the Axonics r-SNM System.

AO, icotec Join Forces on New Spinal Stabilization System

Retrieved on: 
Tuesday, March 3, 2020
Prosthetics, Organic compounds, Polymers, Cryogenics, Magnetic resonance imaging, Implant, Spinal tumor, Chemistry, Polyether ether ketone

DAVOS, Switzerland, March 3, 2020 /PRNewswire/ -- The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec's proprietary BlackArmor Carbon/PEEK composite implant material.

Key Points: 
  • DAVOS, Switzerland, March 3, 2020 /PRNewswire/ -- The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec's proprietary BlackArmor Carbon/PEEK composite implant material.
  • "Patients, surgeons, and radio-oncologists depend on artefact-free imaging, accurate radiation therapy, and reliable post-operative follow-up for the optimal treatment of spinal tumors and metastases.
  • Image artefacts of metal implants in different imaging modalities such as x-ray, CT, and MRI are a well-known obstacle in patient follow-up.
  • icotec AG is a family-owned SME in Altstaetten, Switzerland established in 1999. icotec designs and manufactures nonmetallic spinal implants made from BlackArmor (Carbon/PEEK).

AO, icotec Join Forces on New Spinal Stabilization System

Retrieved on: 
Tuesday, March 3, 2020
Prosthetics, Organic compounds, Polymers, Cryogenics, Magnetic resonance imaging, Implant, Spinal tumor, Chemistry, Polyether ether ketone

DAVOS, Switzerland, March 3, 2020 /PRNewswire/ -- The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec's proprietary BlackArmor Carbon/PEEK composite implant material.

Key Points: 
  • DAVOS, Switzerland, March 3, 2020 /PRNewswire/ -- The AO Foundation and icotec ag announce the successful agreement and kick-off for the joint development of a new spinal stabilization system based on icotec's proprietary BlackArmor Carbon/PEEK composite implant material.
  • "Patients, surgeons, and radio-oncologists depend on artefact-free imaging, accurate radiation therapy, and reliable post-operative follow-up for the optimal treatment of spinal tumors and metastases.
  • Image artefacts of metal implants in different imaging modalities such as x-ray, CT, and MRI are a well-known obstacle in patient follow-up.
  • icotec AG is a family-owned SME in Altstaetten, Switzerland established in 1999. icotec designs and manufactures nonmetallic spinal implants made from BlackArmor (Carbon/PEEK).

Open System MRI Industry Analysis, 2020 to 2025 - Increasing Number of MRI Procedures and Product Launches Drives Growth

Retrieved on: 
Monday, March 2, 2020
Cryogenics, Magnetic resonance imaging, Safety of magnetic resonance imaging

DUBLIN, March 2, 2020 /PRNewswire/ -- The "Open System MRI Market - Growth, Trends And Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 2, 2020 /PRNewswire/ -- The "Open System MRI Market - Growth, Trends And Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • Open MRI is the more popular one between the two available systems of MRI, open and closed.
  • Open MRI systems have a magnetic field in the top and bottom and do not enclose the patient in a tunnel.
  • Conventional MRI scanners are a cylinder shape, while an open MRI does not completely surround your body.

RSNA: MRI Shows Blood Flow Differs in Men and Women, According to New Research

Retrieved on: 
Thursday, February 27, 2020
Magnetic resonance imaging, Cryogenics, Cardiovascular physiology, Medicine, Medical physics, Branches of biology, Cardiac imaging, Applied sciences, Perfusion scanning, Cardiac output

However, much less is known about the way that blood flows through the hearts of men and women and how that relates to cardiac performance.

Key Points: 
  • However, much less is known about the way that blood flows through the hearts of men and women and how that relates to cardiac performance.
  • They derived various blood flow parameters from MRI scans obtained from 20 men and 19 women and correlated them with cardiac function.
  • Dr. Rutkowski emphasized that the ability of 4D flow MRI to provide numbers for various blood flow parameters is especially important.
  • "Getting blood flow and velocity information is just one more metric that is being developed to make MRI more quantitative."

Cryogenic Equipment Market to Reach USD 31.68 Billion by 2026; Rising Investment in LNG-based Plants to Boost Growth, says Fortune Business Insights™

Retrieved on: 
Wednesday, February 26, 2020
Industrial gases, Cryogenics, Fields of mathematics, Compound annual growth rate, Academic disciplines, Applied mathematics

The report further states that the cryogenic equipment market size is projected to reach USD 31.68 billion by 2026, thereby exhibiting a CAGR of 7.1% during the forecast period.

Key Points: 
  • The report further states that the cryogenic equipment market size is projected to reach USD 31.68 billion by 2026, thereby exhibiting a CAGR of 7.1% during the forecast period.
  • In-depth details about the cryogenic equipment market trends, opportunities, challenges, growth drivers, and obstacles.
  • Amongst these, Asia Pacific generated a cryogenic equipment market revenue of USD 6.07 billion in 2018.
  • List of the most prominent companies operating in the cryogenic equipment market.

Cryogenic Equipment Market to Reach USD 31.68 Billion by 2026; Rising Investment in LNG-based Plants to Boost Growth, says Fortune Business Insights™

Retrieved on: 
Wednesday, February 26, 2020
Industrial gases, Cryogenics, Fields of mathematics, Compound annual growth rate, Academic disciplines, Applied mathematics

The report further states that the cryogenic equipment market size is projected to reach USD 31.68 billion by 2026, thereby exhibiting a CAGR of 7.1% during the forecast period.

Key Points: 
  • The report further states that the cryogenic equipment market size is projected to reach USD 31.68 billion by 2026, thereby exhibiting a CAGR of 7.1% during the forecast period.
  • In-depth details about the cryogenic equipment market trends, opportunities, challenges, growth drivers, and obstacles.
  • Amongst these, Asia Pacific generated a cryogenic equipment market revenue of USD 6.07 billion in 2018.
  • List of the most prominent companies operating in the cryogenic equipment market.

Profound Medical Participate in March Investor Healthcare Conferences

Retrieved on: 
Wednesday, February 26, 2020
Cryogenics, Magnetic resonance imaging, Ultrasound, Medical physics

TORONTO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company focused on customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will participate in two investor conferences in March.

Key Points: 
  • TORONTO, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company focused on customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (MRI), thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that management will participate in two investor conferences in March.
  • BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2020: Profound is scheduled to participate in a series of one-on-meetings on March 18, 2020 in Snowbird, UT.
  • Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
  • Profound is commercializing TULSA-PRO, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control.

Sumitomo Heavy Industries (SHI) and Highview Power Partner to Expand Cryogenic Long-Duration Energy Storage Globally

Retrieved on: 
Tuesday, February 25, 2020
Alternative energy, Manufacturing, Other Manufacturing, Energy, Utilities, Articles, Energy, Renewable energy, Cryogenic energy storage, Cryogenics, Energy economics, Highview, Sumitomo Heavy Industries, Energy storage, Sustainable energy, Highview Power, Sumitomo Heavy Industries, Sumitomo SHI FW

Sumitomo Heavy Industries, Ltd. (SHI), a technology leader in industrial machinery and environmental and power technologies, and Highview Power, a global leader in long-duration energy storage solutions, are pleased to announce that the two companies have partnered to expand cryogenic energy storage projects globally.

Key Points: 
  • Sumitomo Heavy Industries, Ltd. (SHI), a technology leader in industrial machinery and environmental and power technologies, and Highview Power, a global leader in long-duration energy storage solutions, are pleased to announce that the two companies have partnered to expand cryogenic energy storage projects globally.
  • As part of this partnership, SHI has made a USD $46 million investment into Highview Power, which signifies SHIs move into the clean energy storage market.
  • Javier Cavada, President and CEO of Highview Power, said, Highview is proud to have a partner like Sumitomo Heavy Industries next to us as we further our global expansion.
  • Highview Power is a designer and developer of the CRYOBattery, a proprietary cryogenic energy storage system that delivers reliable and cost-effective long-duration energy storage to enable a 100 percent renewable energy future.